Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/21236730

Download in:

View as

General Info

PMID
21236730